Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India ...

Designed to reduce daily insulin injections to a single weekly dose, the long-acting insulin aims to improve treatment ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Awiqli cuts basal insulin dosing from seven injections a week to one. Novo Nordisk India MD Vikrant Shrotriya discusses price ...

Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to ...

Insulin resistance may quietly reduce fertility in both men and women, even before diabetes develops. Fertility experts ...

Met a bulin, a Texas-based biotechnology company led by Hua Tu, PhD, is working to develop an ultra-stable insulin formulation that remains viable even at high temperatures. “Insulin instability has ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

Novo Nordisk has launched Awiqli, a once-weekly basal insulin, in India. This innovation offers a significant reduction from ...